CC Chemours Co
Company Analysis
Latest News
Chemours Faces Securities-Fraud Suit Over Opteon Demand and 2026 Guidance
Multiple law firms announced the filing of a securities-fraud class-action lawsuit against The Chemours Company. The lawsuit alleges that the company and its...
🔴 Chemours is trading 4.22% down now at $12.82 after RBC downgrade to Sector Perform
Chemours is trading 4.22% lower at $12.82 after RBC downgrade. - RBC downgraded it to Sector Perform from Outperform and cut its target to $14 from $22. - RBC...
Chemours Faces Court Threat Over Alleged 2019 PFAS Order Violations
Cape Fear River Watch and the Southern Environmental Law Center have formally accused Chemours of violating a 2019 consent order. In a notice letter, the...
🟢 Chemours is trading 6.7% up in after-hours trading with no company catalyst identified
Chemours is trading at $15.43, up 6.71% after hours in a sharp move with no specific catalyst established. - The price compares with a regular-session close...
🔴 Chemours is trading 4.2% down today as Treasury yields surged
Chemours is trading at $14.12, down 4.21%, after higher Treasury yields pressured equity valuations on September 24, 2026. • The 10-year Treasury yield surged...
🔴 Chemours is trading 5% down in pre-market as higher Treasury yields pressure equities
Chemours is trading 4.95% lower at $14.01 as higher Treasury yields weigh on equity valuations. - No company-specific announcement or earnings catalyst was...
Chemours Sued Again Over PFAS Contamination, Months After Previous Settlement
Chemours faces a new proposed class-action lawsuit filed on September 19, 2026. Residents near the Washington Works plant in Wood County, West Virginia, allege...
Chemours, DuPont, and Corteva Reach $455M PFAS Settlement with North Carolina
The Chemours Company, along with DuPont and Corteva, entered into a settlement agreement with the State of North Carolina and 11 local entities to resolve all...
Chemours Pitches a $1 Billion Earnings Target and an AI Cooling Story — But Can a Heavily Indebted Chemical Maker Deliver?
Shares of Chemours Co. surged 6.4% to $16.01 on September 10, bucking softer U.S. equity futures, after the specialty chemicals firm unveiled an investor...
🟢 Chemours is trading 6% up in pre-market after outlining Pathway to Thrive strategy
Chemours is trading 6.43% up now at $16.01 after releasing a September 9 investor presentation outlining its Pathway to Thrive strategy and long-term target of...
Chemours Outlines Strategy Targeting Over $1B Adj. EBITDA and AI Market Growth
The Chemours Company released a new investor presentation detailing its strategic plan, "Pathway to Thrive," which reaffirms key financial targets and...
🔴 Chemours is trading 4.14% down in pre-market; catalyst unclear
Chemours is trading 4.14% down at $15.03 after closing at $15.68 on September 2, 2026; the catalyst remains unclear. - No fresh company-specific announcement,...
🟢 Chemours is trading 4.1% up today as Materials stocks gain 1.60%
Chemours is trading 4.1% up at $15.71, likely reflecting broader materials-sector strength as Materials stocks gain 1.60% during the September 2, 2026...
🔴 Chemours is trading 4.1% down today
Chemours is trading lower with no clear company-specific catalyst identified for the decline. - Trading at $15.31, down -4.10% on August 24, 2026. - No new...
🟢 Chemours is trading 5% up today amid broader chemicals and materials-sector strength
Chemours is trading 5.12% up now at $16.21, mainly as chemicals and materials stocks strengthen amid expectations for improving automotive and construction...
Chemours launches AI data center refrigerants as insider buys shares
The Chemours Company expanded its low-global-warming-potential (GWP) portfolio with the launch of Opteon ZE and Opteon 515B refrigerants. These products target...
🟢 Chemours is trading 4.23% up today
Chemours is trading 4.23% up at $15.81, with no new company-specific announcement on August 14, 2026, clearly explaining the advance. - The stock is trading...
Chemours Downgraded to 'Strong Sell' by Zacks Research
Zacks Investment Research downgraded Chemours Co. (CC) from "Strong-Buy" to "Strong Sell" in a report issued on Tuesday, August 11. The downgrade reverses the...
🟢 Chemours is trading 4.5% up today as broader markets rebound
Chemours is trading 4.5% up at $15.47 as U.S. equities move higher. - Nasdaq Composite is up 0.78% and the S&P 500 is up 0.35%. - No verified company-specific...
🟢 Chemours is trading 4.39% up in after-hours trading with no verified company-specific catalyst identified
Chemours is trading $15.45 (+4.39%) with no verified August 11 company-specific after-hours announcement or late-breaking catalyst identified. - It closed at...